Press release -

Vironova in the ​finals of the Third China Innovation & Entrepreneurship International Competition in Shenzhen

Vironova won the ”Swedish Overseas Division Competition” on March 26th in the ”Third China Innovation & Entrepreneurship International Competition 2019”. Pre- and partcompetitions were held in nine cities that are at the forefront of technological development globally: Stockholm, London, Berlin, Sydney, Tokyo, Tel Aviv, Silicon Valley, Boston and Toronto.

Vironova will participate in the finals of the Third China Innovation & Entrepreneurship International Competition on April 10-12, in Shenzhen, China. A competition which aims to integrate innovation and entrepreneurship resources and help over 100 foreign innovation and entrepreneurship projects to connect with Chinese hi-tech industrial resources and expand the Chinese market for mutual benefits and win-win results.

In addition to being able to measure up against international competition and win prize money, the competition is a good opportunity to develop contacts with the Chinese business community.

For more information contact mohammed.homman@vironova.com

Topics

  • Medical research

Categories

  • innovation
  • vironova
  • award

Vironova is a Swedish biotechnology company providing comprehensive, hardware, software and services for the analysis of nanoparticles. Vironova revolutionizes access to transmission electron microscopy (TEM)-based image analysis in biopharmaceutical development. Our solution enables automated analyses for faster and better-informed decisions to secure robust bioprocessing and final product quality.

The Vironova offering comprises:

  • Cost effective, fast Electron Microscopy (EM) services enabled by the in-house developed Vironova Analyzing Software (VAS) designed for semi-automated nanoparticle analysis
  • Viral clearance testing performed in GLP and BSLIII certified laboratories
  • MiniTEM™, a bench-top Transmission Electron Microscope system designed for automated nanoparticle characterization. High-resolution images reveal particle morphologies that are transformed into accurate metrics.

Contacts

Josefina Nilsson

Press contact CEO

Related events